REVIEW
Add like
Add dislike
Add to saved papers

First degree atrioventricular block.

First degree A-V block, defined as prolongation of the PR interval on the surface electrocardiogram, is a not uncommon finding on electrocardiographic screening of asymptomatic young individuals. Prevalences of from 0.65% to 1.1% have been reported. In the majority of cases the PR prolongation may be rendered normal by autonomic intervention. Long-term follow-up studies have indicated that although the risk of subsequent coronary artery disease may be slightly increased, the risk of sudden death, syncope or advanced A-V block is not. Apart from the exclusion of organic heart disease, detailed invasive investigation is not warranted. It is a benign condition and as such no restriction on fitness to fly need be made on these individuals, but there may be a case for increased electrocardiographic scrutiny.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app